Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subcutaneous Emphysema”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNo Longer AvailableNCT03172455
What this trial is testing

Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Acute-graft-versus-host DiseaseSteroid Refractory Acute Graft Versus Host DiseaseGraft-versus-host-disease+5 more
Impatients N.V. trading as myTomorrows
Not applicableStudy completedNCT00001462
What this trial is testing

Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals

Who this might be right for
EmphysemaLung Diseases, ObstructiveAlpha 1-Antitrypsin Deficiency
National Heart, Lung, and Blood Institute (NHLBI) 60
Testing effectiveness (Phase 2)WithdrawnNCT03385395
What this trial is testing

Study Comparing Weekly Intravenous Administration of OctaAlpha1 With a Marketed Preparation Glassia® in Subjects With Alpha-1-antitrypsin Deficiency

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Octapharma
Testing effectiveness (Phase 2)Study completedNCT03008915
What this trial is testing

Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency

Who this might be right for
Alpha-1 Antitrypsin DeficiencyEmphysemaChronic Obstructive Pulmonary Disease
Columbia University 15
Testing effectiveness (Phase 2)Study completedNCT00263887
What this trial is testing

Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients (EXACTLE)

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Grifols Therapeutics LLC 77
Post-approval studies (Phase 4)Study completedNCT00261833
What this trial is testing

Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency

Who this might be right for
Alpha1-proteinase Inhibitor DeficiencyEmphysema
CSL Behring 180
Early research (Phase 1)Study completedNCT05727800
What this trial is testing

A Phase 1, First-in-human Study of VX-668

Who this might be right for
Alpha-1 Antitrypsin Deficiency
Vertex Pharmaceuticals Incorporated 114
Not applicableEnrolling By InvitationNCT00884455
What this trial is testing

Alpha-1 Foundation DNA and Tissue Bank

Who this might be right for
Alpha 1 Antitrypsin Deficiency
University of Florida 5,000
Testing effectiveness (Phase 2)Study completedNCT01669421
What this trial is testing

Effect of Double Dose of Alpha 1-antitrypsin Augmentation Therapy on Lung Inflammation.

Who this might be right for
Alpha 1 Antitrypsin Deficiency
Michael Campos, MD 10
Not applicableStudy completedNCT03804021
What this trial is testing

Long-Term Follow-up Study of ADVM-043

Who this might be right for
Alpha-1 Antitrypsin Deficiency
Adverum Biotechnologies, Inc. 6
Post-approval studies (Phase 4)Ended earlyNCT00313144
What this trial is testing

Aralast alpha1-proteinase Inhibitor Surveillance Study

Who this might be right for
Alpha1-antitrypsin Deficiency
Baxalta now part of Shire 127
Not applicableNot Yet RecruitingNCT07145385
What this trial is testing

Prevalence of Alpha-1 Antitrypsin Deficiency in Non-Cirrhotic Liver Cancer

Who this might be right for
Retrospective Cohort of Patients Diagnosed With HCC on Non-Cirrhotic Liver
University Hospital, Bordeaux 71
Testing effectiveness (Phase 2)Study completedNCT02001688
What this trial is testing

Phase II, Safety and Efficacy Study of Kamada-alpha-1-antitrypsin (AAT) for Inhalation"

Who this might be right for
Alpha-1 Antitrypsin Deficiency
Kamada, Ltd. 36
Not applicableStudy completedNCT02810327
What this trial is testing

Alpha-1 Carrier Genomics Study

Who this might be right for
Alpha-1 Antitrypsin DeficiencyEmphysemaCOPD+1 more
Medical University of South Carolina 117
Post-approval studies (Phase 4)Not Yet RecruitingNCT07326592
What this trial is testing

Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of Respreeza / Zemaira Weekly for 3 Years in Adults With alpha1 Antitrypsin Deficiency (AATD)

Who this might be right for
Alpha1 Antitrypsin DeficiencyAlpha1-Proteinase Inhibitor DeficiencyEmphysema
CSL Behring 270
Testing effectiveness (Phase 2)Ended earlyNCT04764448
What this trial is testing

Belcesiran in Patients With AATLD

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 16
Not applicableStudy completedNCT01676688
What this trial is testing

Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Laboratoire français de Fractionnement et de Biotechnologies 17
Large-scale testing (Phase 3)Active Not RecruitingNCT05899673
What this trial is testing

An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver Disease

Who this might be right for
Alpha1-Antitrypsin Deficiency
Takeda 31
Not applicableLooking for participantsNCT00500123
What this trial is testing

The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

Who this might be right for
Alpha-1 Antitrypsin Deficiency
University of Florida 50,000
Not applicableUnknownNCT00700934
What this trial is testing

Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema

Who this might be right for
Alpha 1-Antitrypsin DeficiencyEmphysema
Assistance Publique - Hôpitaux de Paris 300
Next Page